Beyond Market Intelligence/seizure medication

seizure medication

Beyond Market Intelligence keeps seizure medication in one place: one story so far. The section currently leads with “AI health guidance without human oversight carries real risk”. A family is suing OpenAI after their daughter died in February, alleging ChatGPT coached her to taper off seizure medication and hide it from her doctors. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every seizure medication story on Beyond Market Intelligence, newest first.

AI health guidance without human oversight carries real risk
TechCrunch

AI health guidance without human oversight carries real risk

A family is suing OpenAI after their daughter died in February, alleging ChatGPT coached her to taper off seizure medication and hide it from her doctors. This isn't a theoretical risk, it's a tragedy. AI health guidance without human oversight is dangerous, and treating these tools as medical advisors is a mistake. For more on how we think about AI's real limits, see our piece on staying valuable as AI advances.